Aakash Desai, Associate Director, Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center, shared a post on X:
“My pick of 10 lung cancer trials that will define practice at ASCO2026.
From sunvozertinib in exon20ins to 7-year CROWN data to TRITON in STK11/KEAP1/KRAS; the data is coming. Which one are you watching?”
ASCO 2026 Lung Cancer Preview: Key Trials With Practice-Changing Potential
